Professional
Added to YB: 2024-03-01
Pitch date: 2024-02-02
MEDP [bullish]
Medpace Holdings, Inc.
+69.43%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$292.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
RiverPark/Next Century Growth Fund New Position: Medpace Holdings, Inc.
$MEDP: CRO focused on small/mid biopharma (75-80% small, 15-20% mid). Faster growth niche vs mid/large pharma. Strong foothold, expected sustained robust growth from biotech spend & market share gains with healthy margins.
Read full article (1 min)